Detalles de la búsqueda
1.
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma.
Blood
; 123(20): 3073-9, 2014 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24646471
2.
A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis.
Br J Haematol
; 170(6): 804-13, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25974382
3.
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Biol Blood Marrow Transplant
; 19(1): 69-74, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22897964
4.
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma.
Br J Haematol
; 163(2): 223-34, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23952215
5.
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
Blood Cancer J
; 11(5): 101, 2021 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34021118
6.
Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.
Blood
; 112(7): 2709-12, 2008 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18594024
7.
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.
Blood
; 112(10): 4017-23, 2008 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18669875
8.
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Biol Blood Marrow Transplant
; 15(4): 512-6, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19285640
9.
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
Haematologica
; 93(4): 560-5, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18322252
10.
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
Eur J Haematol
; 80(3): 227-35, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18088400
11.
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.
J Mol Diagn
; 19(1): 99-106, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27863261
12.
International staging system for multiple myeloma.
J Clin Oncol
; 23(15): 3412-20, 2005 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15809451
13.
Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma.
Leuk Lymphoma
; 56(2): 415-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24828869
14.
Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients.
Int J Hematol
; 93(3): 351-360, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21360065
15.
Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial.
Leuk Lymphoma
; 50(2): 216-22, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19197734
16.
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
J Clin Oncol
; 26(16): 2737-44, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18443352
17.
Impact of the conditioning regimen in patients with multiple myeloma who undergo autologous transplantation.
J Clin Oncol
; 29(15): e449; author reply e450, 2011 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21482988
18.
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study.
Blood
; 108(7): 2165-72, 2006 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16772605
19.
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
J Antimicrob Chemother
; 50(1): 79-88, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12096010
Resultados
1 -
19
de 19
1
Próxima >
>>